Stay updated with breaking news from Peter Rossing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SPOKANE, Wash. — Tomorrow, “Hamilton” will open its 24-show run on May 3 at the First Interstate Center in downtown Spokane. Like many noteworthy events to hit the Lilac City,
Results from FIDELITY, a prespecified analysis of data from two pivotal trials of finerenone, hints of an additive benefit with SGLT2 inhibitors in patients with type 2 diabetes.
Patients with both diabetes and atrial fibrillation may derive greater benefits from non-vitamin K oral anticoagulants than from warfarin, a new study has found.
It is estimated that chronic kidney disease affects more than 160 million people with type 2 diabetes worldwide. - News - PharmaTimes